Prime Medicine PRME
NASDAQ PRME
$4.30 +0.40 (+10.26%)
At close: Nov 11, 2026 · 4:00 PM EST

Prime Medicine (PRME) Selling, General & Administrative (2021 - 2026)

Updated

Prime Medicine (PRME) recorded Selling, General & Administrative of $11.04 million in Q2 2026, down 15.8% from $13.12 million a year earlier and down 36.6% from the prior quarter.

Analysis

Prime Medicine (PRME) Selling, General & Administrative (2021 - 2026) Analysis & Trends

On a TTM basis, Prime Medicine's Selling, General & Administrative came in at $54.39 million as of Jun 30, 2026, up 3.0% year-over-year; for FY2025, it came in at $52.35 million, up 4.4% from FY2024.

  • Annual Selling, General & Administrative has increased for five straight years, with a five-year compound annual growth rate of 75.3% (FY2020 to FY2025).
  • Across earlier years, Selling, General & Administrative came in at $50.16 million in FY2024 (+15.6%), $43.39 million in FY2023 (+45.5%), $29.82 million in FY2022 (+114.2%) and $13.92 million in FY2021 (+340.4%).
  • The Q2 2026 figure is the lowest quarterly Selling, General & Administrative since Q3 2023.
  • On a year-over-year basis, Selling, General & Administrative rose in five of the last eight quarters, with growth averaging 8.3%.
  • Peak year-over-year performance for Selling, General & Administrative in the last five years was growth of 118.3% in Q3 2022, against a decline of 20.5% in Q3 2025 at the low end.
  • Per Business Quant, the preceding three quarters came in at $17.41 million (Q1 2026), $14.74 million (Q4 2025) and $11.21 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) SG&A (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn 3.13 Bn
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn 6.29 Bn
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn 4.09 Bn
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn 2.89 Bn
5 Novartis Ag 311.58 Bn 285.16 Bn - -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn 5.11 Bn
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn 1.68 Bn
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn 1.64 Bn
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn 3.28 Bn
10 Prime Medicine 704.88 Mn 469.45 Mn - 11.04 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 11.04 Mn
Mar 31, 2026 17.41 Mn
Sep 30, 2025 11.21 Mn
Jun 30, 2025 13.12 Mn
Mar 31, 2025 13.28 Mn
Dec 31, 2024 12.30 Mn
Sep 30, 2024 14.10 Mn
Jun 30, 2024 12.60 Mn
Mar 31, 2024 11.16 Mn
Dec 31, 2023 13.08 Mn
Sep 30, 2023 10.49 Mn
Jun 30, 2023 10.66 Mn
Mar 31, 2023 9.15 Mn
Dec 31, 2022 9.63 Mn
Sep 30, 2022 6.61 Mn
Jun 30, 2022 7.37 Mn
Mar 31, 2022 6.22 Mn
Dec 31, 2021 7.19 Mn
Sep 30, 2021 3.03 Mn
API Access

Prime Medicine Selling, General & Administrative API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=selling-general-and-administrative&ticker=PRME&period=max&api_key=YOUR_API_KEY